These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6749526)

  • 1. The effect of food on the bioavailability and pharmacodynamics of tolbutamide in diabetic patients.
    Antal EJ; Gillespie WR; Phillips JP; Albert KS
    Eur J Clin Pharmacol; 1982; 22(5):459-62. PubMed ID: 6749526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of food and tablet age on relative bioavailability and pharmacodynamics of two tolbutamide products.
    Olson SC; Ayres JW; Antal EJ; Albert KS
    J Pharm Sci; 1985 Jul; 74(7):735-40. PubMed ID: 4032245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolbutamide affects food ingestion in a manner consistent with its glycemic effects in the rat.
    Vanderweele DA; Haraczkiewicz E; Vasselli JR
    Physiol Behav; 1988; 44(4-5):679-83. PubMed ID: 3070588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes.
    Linnebjerg H; Kothare PA; Skrivanek Z; de la Peña A; Atkins M; Ernest CS; Trautmann ME
    Diabet Med; 2006 Mar; 23(3):240-5. PubMed ID: 16492205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin responses to nonglucose stimuli in non-insulin-dependent diabetes mellitus during a tolbutamide infusion.
    Pfeifer MA; Halter JB; Beard JC; Judzewitsch R; Porte D
    Diabetes; 1982 Feb; 31(2):154-9. PubMed ID: 6759232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of naproxen on glucose metabolism and tolbutamide kinetics and dynamics in maturity onset diabetics.
    Whiting B; Williams RL; Lorenzi M; Varady JC; Robins DS
    Br J Clin Pharmacol; 1981 Mar; 11(3):295-302. PubMed ID: 7213531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. alpha-Glucosidase inhibition improves postprandial hyperglycemia and decreases insulin requirements in insulin-dependent diabetes mellitus.
    Dimitriadis GD; Tessari P; Go VL; Gerich JE
    Metabolism; 1985 Mar; 34(3):261-5. PubMed ID: 3883097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of tolbutamide, glucose, and insulin interrelationships following varying doses of intravenous tolbutamide in normal subjects.
    Ganda OP; Kahn CB; Soeldner JS; Gleason RE
    Diabetes; 1975 Apr; 24(4):354-67. PubMed ID: 1132601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effects of tolazamide and tolbutamide upon blood glucose and serum insulin and lipid levels in diabetic subjects.
    Moorhouse JA
    Can Med Assoc J; 1967 Mar; 96(9):536-9. PubMed ID: 6019354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics.
    Bramer SL; Forbes WP
    Clin Pharmacokinet; 1999; 37 Suppl 2():13-23. PubMed ID: 10702883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of single-dose orlistat on postprandial serum glucose, insulin and glucagon-like peptide-1 levels in nondiabetic obese patients.
    Sahin M; Tanaci N; Yucel M; Tutuncu NB; Guvener N
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):346-50. PubMed ID: 17524030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin response to glucagon with or without tolbutamide in normal and diabetic subjects.
    Chiba M; Ohneda A; Sakai T; Goto Y
    Tohoku J Exp Med; 1982 Feb; 136(2):169-75. PubMed ID: 7041329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects.
    Wåhlin-Boll E; Melander A; Sartor G; Scherstén B
    Eur J Clin Pharmacol; 1980 Oct; 18(3):279-83. PubMed ID: 7002565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orlistat augments postprandial increases in glucagon-like peptide 1 in obese type 2 diabetic patients.
    Damci T; Yalin S; Balci H; Osar Z; Korugan U; Ozyazar M; Ilkova H
    Diabetes Care; 2004 May; 27(5):1077-80. PubMed ID: 15111524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of salicylate, tolbutamide, and prostaglandin E2 on insulin responses to glucose in noninsulin-dependent diabetes mellitus.
    Giugliano D; Ceriello A; Saccomanno F; Quatraro A; Paolisso G; D'Onofrio F
    J Clin Endocrinol Metab; 1985 Jul; 61(1):160-6. PubMed ID: 3923028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of food and age on the single-dose kinetics and effects of tolbutamide and chlorpropamide.
    Sartor G; Melander A; Scherstén B; Wåhlin-Boll E
    Eur J Clin Pharmacol; 1980 Apr; 17(4):285-93. PubMed ID: 6995130
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of glucagon secretion during a tolbutamide infusion in normal and noninsulin-dependent diabetic subjects.
    Pfeifer MA; Beard JC; Halter JB; Judzewitsch R; Best JD; Porte D
    J Clin Endocrinol Metab; 1983 Mar; 56(3):586-91. PubMed ID: 6337181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of insulin secretion in non-insulin-dependent diabetes mellitus by two novel oral hypoglycaemic agents, NN623 and A4166.
    Kikuchi M
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S151-5. PubMed ID: 8894500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation of postprandial plasma glucose, palatability, and symptoms associated with a standardized mixed test meal versus 75 g oral glucose.
    Wolever TM; Chiasson JL; Csima A; Hunt JA; Palmason C; Ross SA; Ryan EA
    Diabetes Care; 1998 Mar; 21(3):336-40. PubMed ID: 9540012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-induced insulin secretion in normal diabetic subjects.
    Ohneda A; Matsuda K; Chiba M; Iimura Y; Yamagata S
    Tohoku J Exp Med; 1975 Jun; 116(2):103-10. PubMed ID: 1154379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.